BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 01, 2015
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
CompanyBankAnalystCoverageOpinionWk chg5/29 cls
Blueprint Medicines Corp. (NASDAQ:BPMC)CowenEric SchmidtNewOutperform-4%$28.69
WedbushDavid NierengartenNewOutperform
Schmidt initiated coverage, saying the company has "created a unique kinase-specific chemical library that enables...

Read the full 255 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >